For: | Meng M, Shi LL. Serum tumor markers expression (CA199, CA242, and CEA) and its clinical implications in type 2 diabetes mellitus. World J Diabetes 2024; 15(2): 232-239 [PMID: 38464372 DOI: 10.4239/wjd.v15.i2.232] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i2/232.htm |
Number | Citing Articles |
1 |
Xiafei Zhao, Yan Wang, Ling Zhou, Aili Ye, Quanfeng Zhu. Changes of CA19-9 levels and related influencing factors in patients with type 2 diabetes mellitus after antidiabetic therapy. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-85807-4
|
2 |
Kotha Sugunakar Reddy, Ilakkiya Priya Pandiaraj, Archana Gaur, Sakthivadivel Varatharajan. Serum tumor markers: Can they clinically implicate in type 2 diabetes mellitus?. World Journal of Diabetes 2024; 15(7): 1648-1650 doi: 10.4239/wjd.v15.i7.1648
|
3 |
Xinxin Wo, Xiaoyan Yu, Lingling Miao, Yushan Mao, Keke Tang. Diabetic Ketoacidosis in Klinefelter Syndrome Sans Malignancy with Unusually Elevated Levels of CEA: A Case Report. Diabetes, Metabolic Syndrome and Obesity 2025; : 233 doi: 10.2147/DMSO.S498230
|